CLOUDBREAK PHARMA INC. - B
(HKEX: 2592)
Cloudbreak Pharma, Inc. is an investment holding company, which engages in the research and development of therapeutic biologics. Its pipeline includes CBT-001, CBT-009, CBT-004, CBT-006, CBT-199, CBT-145, CBT-007, and CBT-011. The company was founded by Jin Song Ni, Van Son Dinh, and Jun Zhi Li in September 2015 and is headquartered in Irvine, CA.
2.280 -
-0.100
(-4.20%)
价格区间
2.260 - 2.340
(3.54%)
开盘
2.290
昨收
2.380
买
2.260
买盘
('000)
11
卖
2.280
卖盘
('000)
11
成交量
('000)
518
成交额
1,187,795
注释
-
数据延迟。最后一次更新12 Feb 2026 16:08.
数据提供商
查看所有活动
Loading Chart...
Please login to view stock data and analysis
